Literature DB >> 7564431

The Carpentier-Edwards pericardial aortic valve. Ten-year results.

D M Cosgrove1, B W Lytle, P C Taylor, M T Camacho, R W Stewart, P M McCarthy, D P Miller, M R Piedmonte, F D Loop.   

Abstract

To evaluate the function of the Carpentier-Edwards pericardial valve in the aortic position, we analyzed the results of 310 aortic valve replacements performed between 1982 and 1985. Mean age was 64.2 +/- 10.8 years (range 22 to 95 years); 190 patients (61.3%) were male patients. There were 18 hospital deaths (5.8%), and none were valve related. Follow-up of the 292 survivors was 100% complete at a mean of 7.8 +/- 2.9 years; 2290 patient-years of follow-up were available for analysis. There were 133 late deaths (45.5%). Actuarial survivals at 5 and 10 years were 82.5% and 45.9%, respectively. The 10-year actuarial freedom from events was 88.7% +/- 2.1% for thromboembolism, 90.9% +/- 1.8% for hemorrhage, 94.3% +/- 1.6% for endocarditis, and 91.2% +/- 2.6% for structural deterioration. The 153 hospital survivors 65 years of age or older had an extremely low incidence of structural valve deterioration, with only four explants and 95.5% actuarial freedom from explantation at 10 years, and a linearized rate of 0.3 +/- 0.2 per patient-year compared with 88.6% and 0.7 +/- 0.2 for patients younger than 65 years of age. Twelve valves were explanted for structural deterioration. Of these, 11 (93%) had leaflet calcification causing stenosis and one had a wear-related leaflet tear. The Carpentier-Edwards pericardial valve has a low incidence of valve-related complications. The freedom from structural valve deterioration is low at 10 years, particularly in patients 65 years of age and older.

Entities:  

Mesh:

Year:  1995        PMID: 7564431     DOI: 10.1016/S0022-5223(95)70096-X

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Carpentier-Edwards pericardial aortic valve in middle-aged patients: comparison with the St. Jude Medical valve.

Authors:  Yoshimasa Sakamoto; Kazuhiro Hashimoto; Hiroshi Okuyama; Shinichi Ishii; Takahiro Inoue; Katsushi Kinouchi; Takayuki Abe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-09

2.  Primary echocardiographic results of the Carpentier-Edwards Perimount Magna.

Authors:  Hiroki Mizoguchi; Masayuki Sakaki; Kazushige Inoue; Yasuhiko Kobayashi; Takashi Iwata; Yasuo Suehiro; Takuya Miura
Journal:  J Med Ultrason (2001)       Date:  2012-04-05       Impact factor: 1.314

3.  Preparation of in-vivo tissue-engineered valved conduit with the sinus of Valsalva (type IV biovalve).

Authors:  Masashi Yamanami; Yuki Yahata; Tsutomu Tajikawa; Kenkichi Ohba; Taiji Watanabe; Keiichi Kanda; Hitoshi Yaku; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2010-03-06       Impact factor: 1.731

4.  Hemodynamic Performance of Pericardial Bioprostheses in the Aortic Position.

Authors:  Haeju Lee; Ho Young Hwang; Suk Ho Sohn; Jae Woong Choi; Jun-Bean Park; Kyung Hwan Kim; Ki-Bong Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2020-10-05

5.  In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model.

Authors:  Yoshiaki Takewa; Masashi Yamanami; Yuichiro Kishimoto; Mamoru Arakawa; Keiichi Kanda; Yuichi Matsui; Tomonori Oie; Hatsue Ishibashi-Ueda; Tsutomu Tajikawa; Kenkichi Ohba; Hitoshi Yaku; Yoshiyuki Taenaka; Eisuke Tatsumi; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2012-12-20       Impact factor: 1.731

6.  Late outcome analysis of the Braile Biomédica® pericardial valve in the aortic position.

Authors:  Lisandro Gonçalves Azeredo; Elinthon Tavares Veronese; José Augusto Duncan Santiago; Carlos Manuel de Almeida Brandão; Pablo Maria Alberto Pomerantzeff; Fabio Biscegli Jatene
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.